Cargando…
COVID-19 in Patients with Atopic Dermatitis Treated with Dupilumab: Three Cases and a Literature Review
There are limited clinical data on the impact of the SARS-CoV2 infection on patients with dermatological conditions treated with biologics. Dupilumab is a recombinant human IgG(4) human monoclonal antibody that inhibits IL4 and IL13 signaling, and is used for moderate–severe atopic dermatitis treatm...
Autores principales: | Ceryn, Justyna, Niedźwiedź, Michał, Skibińska, Małgorzata, Ciążyńska, Magdalena, Lesiak, Aleksandra, Narbutt, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407774/ https://www.ncbi.nlm.nih.gov/pubmed/34475772 http://dx.doi.org/10.2147/CCID.S321003 |
Ejemplares similares
-
Off-label medications in the treatment of hospitalized children with atopic dermatitis
por: Niedźwiedź, Michał, et al.
Publicado: (2022) -
Secukinumab for the Treatment of Psoriasis in Pediatrics: Patient Selection and Acceptability
por: Narbutt, Joanna, et al.
Publicado: (2023) -
Tumor of the Nose – A Rare Manifestation of a Metastatic Lung Cancer
por: Bolewska, Aleksandra, et al.
Publicado: (2021) -
Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients
por: Sieniawska, Joanna, et al.
Publicado: (2022) -
Pemphigoid Gestationis – Case Report and Review of Literature
por: Ceryn, Justyna, et al.
Publicado: (2021)